Evidence map›Paper›PMID 25054153›Full record

ReviewBioMed research international2014

Dissecting the role of bone marrow stromal cells on bone metastases.

Denise Buenrostro, Serk In Park, Julie A Sterling

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Role of prostate and bone stromal cells on prostate cancer progression.American journal of clinical and experimental urology · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment.Endocrinology and metabolism (Seoul, Korea) · 2016
    Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Denise BuenrostroDepartment of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 37212, USA ; Center for Bone Biology, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University, 2215B Garland Avenue, 1235 MRBIV, Nashville, TN 37232, USA.
Serk In ParkCenter for Bone Biology, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University, 2215B Garland Avenue, 1235 MRBIV, Nashville, TN 37232, USA ; Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA.
Julie A SterlingDepartment of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN 37212, USA ; Center for Bone Biology, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University, 2215B Garland Avenue, 1235 MRBIV, Nashville, TN 37232, USA ; Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA.
Vanderbilt University · USVA Tennessee Valley Healthcare System · US

Funding

Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
TRAINING PROGRAM IN CELLULAR, BIOCHEMICAL, &MOLECULAR ST32GM008554 · NIGMS · VANDERBILT UNIVERSITY · PI PATTON, JAMES G. · 1995 to 2020
$7.4M
The Role of Mechanotransduction in Progression of Tumor-induced Bone DiseaseR01CA163499 · NCI · VANDERBILT UNIVERSITY · PI GUELCHER, SCOTT A, RHOADES (STERLING), JULIE A · 2012 to 2016
$1.5M
Targeting the Bone Microenvironment to Reduce Tumor-induced Bone DiseaseI01BX001957 · VA · VETERANS HEALTH ADMINISTRATION · PI RHOADES (STERLING), JULIE A · 2013 to 2025
–
BLRD VA I01 BX001957NCI NIH HHS 1R01CA163499NCI NIH HHS R01 CA163499NIGMS NIH HHS R25 GM062459NIGMS NIH HHS T32 GM008554
6 · The paper itself

Abstract

Tumor-induced bone disease is a dynamic process that involves interactions with many cell types. Once metastatic cancer cells reach the bone, they are in contact with many different cell types that are present in the cell-rich bone marrow. These cells include the immune cells, myeloid cells, fibroblasts, osteoblasts, osteoclasts, and mesenchymal stem cells. Each of these cell populations can influence the behavior or gene expression of both the tumor cells and the bone microenvironment. Additionally, the tumor itself can alter the behavior of these bone marrow cells which further alters both the microenvironment and the tumor cells. While many groups focus on studying these interactions, much remains unknown. A better understanding of the interactions between the tumor cells and the bone microenvironment will improve our knowledge on how tumors establish in bone and may lead to improvements in diagnosing and treating bone metastases. This review details our current knowledge on the interactions between tumor cells that reside in bone and their microenvironment.

Indexed as

Bone and BonesBone NeoplasmsFibroblastsHumansImmune SystemMesenchymal Stem CellsNeoplasm MetastasisNeoplasmsOsteoblastsOsteoclastsTumor Microenvironment

Identifiers

PMID25054153
PMCPMC4099112
OpenAlexW2122359995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.